Peptide Decoding
New?New to peptides?Start here →
Decoding

PT-142_Dosage, benefits & legal status

Also known as PT142

Published August 24, 2026

A Palatin-style code number with no published compound behind it.

Sexual functionUndocumented vendor nameResearch only
DoseResearch only
FrequencyNot established
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is PT-142?

Plain language first. The technical label stays, but it never stands alone.

Overview

A number that looks like it continues Palatin's series, with no compound published behind it. PT-141 is the real one and it has an approved label.

The technical version

No molecule corresponding to the designation PT-142 is characterized in public sources. PT-141 (bremelanotide) is FDA-approved as Vyleesi, and the designation PT-14 appears in patent literature for Melanotan II. This entry records the absence rather than inferring a structure.

What it's used for

A name sold as a successor to PT-141. No published characterization of the compound exists.

02

How does PT-142 work?

What it does in the body, and where.

Palatin Technologies used PT numbers for its melanocortin program, which is what makes the name persuasive.

  1. 01
    PT-141 is bremelanotide, and it is approved
    FDA approved as Vyleesi in 2019 for hypoactive sexual desire disorder in premenopausal women. Sequence, patents and phase III trials all exist.
  2. 02
    PT-14 was Melanotan II
    Patent literature records Melanotan II under the designation PT-14 during its development as Erectide. The numbering is real, and it belongs to specific molecules.
  3. 03
    No record attaches to PT-142
    No sequence, formula, patent or trial for a compound with this designation could be located. A plausible next number in a real series is not the same as a compound.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Sexual function, by implication of the namenone
  • Nothing else can be listed, because nothing is documentednone

The published record

Research index

0

Papers and trials about PT-142

Europe PMC was searched on 12 October 2026 and returned nothing.

Counted from Europe PMC indexing, not read by a person.

PT-142 vial rendering
Compound field notes

At a glance

Four things to know about PT-142

01

Evidence

Research only

02

Category

Sexual and hormonal

03

Common vial

Varies

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, not established. Not established No range

No schedule has been studied for this compound in people.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life can be published for a compound with no established identity.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mcg)
Commonly referenced range: 750 up to 1750 mcgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW15 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized PT-142 keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Uncontrolled high blood pressure or known cardiovascular disease, a documented concern for this drug class
  • Anyone unable to confirm from a certificate of analysis what molecule they have
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Unknown. No study has recorded what this commonly causes, because the compound is not identified

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is PT-142 approved?

And where the numbers on this page come from.

No. PT-142 is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence